Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10201/49388

Registro completo de metadatos
Campo DCValorLengua/Idioma
dc.contributor.authorShakibaei, Mehdi-
dc.contributor.authorBuhrmann, C.-
dc.contributor.authorMobasheri, A.-
dc.date.accessioned2016-04-27T18:41:04Z-
dc.date.available2016-04-27T18:41:04Z-
dc.date.issued2011-
dc.identifier.issn1699-5848-
dc.identifier.issn0213-3911-
dc.identifier.urihttp://hdl.handle.net/10201/49388-
dc.description.abstractTendons have a limited capacity for self-repair due to the low density and mitotic activity of tenocytes. Pro-inflammatory cytokines such as interleukin-1ß (IL-1ß) have been identified as the main initiators of tendinopathies, stimulating inflammation, apoptosis and extracellular matrix (ECM) degradation. The aim of this study was to evaluate the potential of Tendoactive®, a newly developed proprietary nutraceutical formulation that includes mucopolysaccharides, collagen and vitamin C, in an in vitro model of tendon inflammation. The effects of Tendoactive® were studied in primary cultures of human tenocytes treated with IL-1ß for up to 72 h. Expression of collagen type I, integrin ß1, cyclo-oxygenase-2 (COX-2), caspase-3 and matrix metalloproteinase-1 (MMP-1) was monitored by western blotting. The effects of Tendoactive® on the expression, phosphorylation and nuclear translocation of protein components of the NF-κB system were studied by western blotting and immunofluorescence respectively. Treatment of tenocytes with Tendoactive® suppressed IL-1ß-induced NF-κB activation and p65 nuclear translocation. These events correlated with down-regulation of NF-κB targets including COX-2, MMP-1 and activated caspase-3. Tendoactive® also reversed the IL-1ß-induced down-regulation of collagen type I and ß1-integrin receptor expression. These results indicate that Tendoactive® has nutraceutical potential as an anti-inflammatory agent for treating tendinopathy through suppression of NF-κB mediated IL-1ß catabolic signalling pathways in tenocytes.es
dc.formatapplication/pdfes
dc.format.extent13es
dc.languageenges
dc.publisherF. Hernández y J.F. Madrid. Murcia: Universidad de Murcia, Departamento de Biología Celular e Histología.es
dc.relation.ispartofHistology and histopathology, Vol.26, nº9 (2011)es
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.subjectTendinopathyes
dc.subjectTendoactive®es
dc.subject.other61 - Medicinaes
dc.titleAnti-inflammatory and anti-catabolic effects of TENDOACTIVE® on human tenocytes in vitroes
dc.typeinfo:eu-repo/semantics/articlees
Aparece en las colecciones:Vol.26, nº9 (2011)

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
Shakibaei-26-1173-1185-2011.pdf3,03 MBAdobe PDFVista previa
Visualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons